AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company.
Linked as:
Extract
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company.
SAN DIEGO -- AVANIR Pharmaceuticals (NASDAQ:AVNR) announced today that it has entered into a definitive agreement with the shareholders of Alamo Pharmaceuticals, LLC (Alamo) to purchase the Company. Closing is subject to the assumption of debt by the principal shareholder and certain other provisions. Alamo is a privately owned specialty pharmaceutical company with a sales force of approximately fifty representative...
See the full content of this document
Sponsored links
